| Did Sanofi, WHO ignore warning signals on dengue vaccine? | | | CHICAGO/LONDON (Reuters) - When French drugmaker Sanofi published the results of clinical trials of children given its dengue vaccine two years ago, the overall findings were that it protected against the world's biggest and fastest growing mosquito-borne disease. |
| |
| Republicans propose to delay, pause Obamacare taxes | | | WASHINGTON (Reuters) - U.S. House Republicans proposed on Tuesday to delay or suspend several taxes under former President Barack Obama's healthcare law, including a tax on medical devices and the so-called "Cadillac" tax on generous health insurance plans. |
| |
| France's Sanofi pins hopes on new drugs after setbacks | | | PARIS (Reuters) - French pharmaceuticals group Sanofi said on Wednesday it had suffered from low uptake for a new cholesterol drug and from concerns about a dengue vaccine, but expressed confidence its pipeline of new products would support long-term growth. |
| |
| EU renews approval for herbicide glyphosate for five years | | | BRUSSELS (Reuters) - The European Commission said on Tuesday it had renewed for five years the license for the weed-killer glyphosate, a key ingredient in Monsanto Co's top-selling Roundup, following a heated debate over whether it causes cancer. |
| |
| Sanofi investors hungry for drug progress and deal news | | | PARIS (Reuters) - Sanofi still needs to convince markets it can deliver on an exciting and sustainable growth path as it contends with fresh difficulties in its vaccines arm and looks set for another gloomy year in diabetes, investors told Reuters. |
| |
| 'Heat-not-burn' tobacco may be safer but still a risk: UK panel | | | LONDON (Reuters) - A new wave of "heat-not-burn" tobacco products are probably safer than traditional cigarettes but the devices still produce a number of potentially harmful compounds, some of which are carcinogenic, a British panel of experts said on Tuesday. |
| |
| | |
